Search - tctmd.com

Displaying 661 - 680 of 796

Sort: Relevancy | Date

News Conference News ESC 2013

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

September 09, 2013

News Conference News ESC 2013

Cooling, PCI Improves Long-term Outcomes for Cardiac Arrest Survivors

Yael L. Maxwell

September 04, 2013

News Conference News ESC 2013

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Caitlin E. Cox

September 01, 2013

News Daily News

Post-PCI Bleeding Risk Higher in Women, Linked with Mortality

August 30, 2013

News Daily News

Los Riesgos Hemorrágicos Post-PCI son Más Altos en Mujeres que en Hombres y se asocian a la Mortalidad

August 30, 2013

News Daily News

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

August 30, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

Presentation

Triple Antithrombotic Therapy Is the Independent Predictor of Major Bleeding Complications

Presenter: Y. Naruse

August 26, 2013

Presentation

Bleeding After PCI in Women and Men Matched for Age, BMI, and Type of Antithrombotic Therapy

Presenter: Gjin Ndrepepa

August 26, 2013

News Daily News

Nonvalvular A-fib Patients More Likely to Remain on Dabigatran Than Warfarin

Jason Kahn

August 12, 2013

News Daily News

Effect of PCI-Related Bleeding on Mortality Risk Varies by Location

Caitlin E. Cox

August 05, 2013

News Daily News

For A-fib Patients, Aspirin on Top of Anticoagulation Raises Bleeding Risk

Caitlin E. Cox

July 25, 2013

News Daily News

En Pacientes con FA, Aspirina + Anticoagulación Aumenta el Riesgo Hemorrágico

Caitlin E. Cox

July 25, 2013

News Daily News

Meta-Analysis Provides Little Closure to PFO-Stroke Debate

Jason Kahn

July 24, 2013

News Daily News

Oral Anticoagulant Use for A-fib in Community Practice Appears Appropriate

June 21, 2013

News Daily News

El Uso de Anticoagulantes Orales contra la FA en Prácticas de la Comunidad parece Apropiado

June 21, 2013

News Daily News

Un Registro Danés Sugiere que la Aspirina No es Necesaria en Pacientes con FA tras un IM o PCI

Caitlin E. Cox

June 20, 2013

News Daily News

Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI

Caitlin E. Cox

June 20, 2013

News Daily News

ROCKET AF: La Insuficiencia Cardíaca No Resta Validez del Rivaroxaban

Caitlin E. Cox

June 20, 2013

News Daily News

ROCKET AF: Heart Failure Does Not Weaken the Case for Rivaroxaban

Caitlin E. Cox

June 20, 2013

Advertisement

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

Cooling, PCI Improves Long-term Outcomes for Cardiac Arrest Survivors

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Post-PCI Bleeding Risk Higher in Women, Linked with Mortality

Los Riesgos Hemorrágicos Post-PCI son Más Altos en Mujeres que en Hombres y se asocian a la Mortalidad

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

Triple Antithrombotic Therapy Is the Independent Predictor of Major Bleeding Complications

Bleeding After PCI in Women and Men Matched for Age, BMI, and Type of Antithrombotic Therapy

Nonvalvular A-fib Patients More Likely to Remain on Dabigatran Than Warfarin

Effect of PCI-Related Bleeding on Mortality Risk Varies by Location

For A-fib Patients, Aspirin on Top of Anticoagulation Raises Bleeding Risk

En Pacientes con FA, Aspirina + Anticoagulación Aumenta el Riesgo Hemorrágico

Meta-Analysis Provides Little Closure to PFO-Stroke Debate

Oral Anticoagulant Use for A-fib in Community Practice Appears Appropriate

El Uso de Anticoagulantes Orales contra la FA en Prácticas de la Comunidad parece Apropiado

Un Registro Danés Sugiere que la Aspirina No es Necesaria en Pacientes con FA tras un IM o PCI

Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI

ROCKET AF: La Insuficiencia Cardíaca No Resta Validez del Rivaroxaban

ROCKET AF: Heart Failure Does Not Weaken the Case for Rivaroxaban

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content